Navigate Up
Sign In

​MSD is a global healthcare leader working to address unmet health needs. We provide innovative medicines, vaccines, biologic therapies and animal health products to help improve health and well-being. We work with customers in 140 countries to deliver broad-based healthcare solutions. The company is known as Merck & Co., Inc., Kenilworth, NJ, USA in the United States and Canada. Everywhere else, we are known as MSD.


MSD in top 5 of Access to Medicine Index
MSD (Merck & Co.,Inc., in the US) is ranked number 5 on the Access to Medicine Index, up from #7 in the last Index, which was published in 2014. The Access to Medicine Index independently ranks pharmaceutical companies’ efforts to improve access to medicine in developing countries. Funded by the Bill & Melinda Gates Foundation and the UK and Dutch governments, the Index has been published every two years since 2008.
Learn more about our company’s efforts to expand access to health care in Merck and MSD’s Corporate Responsibility Report.
More on The Access to Medicine Index can be found on here.

The advancement of cancer researches under the spotlight thanks to the prestigious Galien Prize:
Deze twee innoverende antikankermedicijnen winnen Galenusprijs (De Morgen - NL).
Galenusprijs geeft kankerpatiënten nieuwe hoop (Knack - NL).
Het beste wapen tegen kanker zit misschien in onszelf (De tijd - NL).
Le Prix Galien offre de nouveaux espoirs de guérison des patients cancéreux (Le Vif - FR).
Prix Galien, pas de soins de santé sans innovation (Le Journal du Médecin - FR - For registered users).

What Belgians think about cancer...
Bijna twee derde van Belgen denkt kanker te krijgen (De Redactie - NL).
Les Belges surestiment la menace du cancer (La DH).
7 Belges sur 10 pensent que le cancer sera vaincu (L'Avenir - FR).
Plus de la moitié des Belges pensent être un jour confrontés au cancer (RTL info -FR).
La peur de contracter le cancer est très élevée parmi la population belge (L'Echo - FR - For registered users).

2015 National Women's Day : focuses on women in the innovative pharmaceutical sector. Many women are actively involved in the innovative pharmaceutical industry. As part of the 2015 National Women's Day, highlights the contribution of women holding a management position within the pharmaceutical sector, among them Patricia Massetti, MD, MSD Belgium and Luxembourg (in French) or (in Dutch).

Phase III Trial of the MSD and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone
MSD confirms that the third, late-stage, clinical trial of their Ebola vaccine candidate rVSV-ZEBOV-GP (V920) has been initiated in Sierra Leone.
Click here to read the article.

“Pour un médicament’, il faut 10.000 idées "
Interview with the journal « Le Soir » met Patricia Massetti, CEO MSD BeLux and Vice President of (in French only)
To learn more about Patricia Massetti in French or in Dutch.

Mectizan/Nobel Prize
In October 2015, it was announced that Dr William C. Campbell is one of the three winners of the 2015 Nobel Prize for Physiology or Medicine. Dr Campbell, who worked for 30 years as an MSD researcher, shares the prize with Satoshi Omura. Together they worked on the original development of ivermectin, a medicine used in the treatment of onchocerciasis - better known as river blindness - affecting millions of people in Africa, Latin America and Yemen.
Discover here the program.

Medecine Nobel Prize 2015
Nobel Prize 2015 in Medicine Awarded to Dr. Campbell, a former scientist of MSD in French or click here for the Dutch.

More news
Please click here to read more news about MSD Belgium & Luxembourg.

​We want to make MSD the pharmaceutical company of choice by recruiting, training and managing the best people. Visit our careers section to learn more about who we are as a company and to discover the many reasons to join MSD.
Learn more


Do you wish to know more about our company MSD? Please take a look at our corporate brochure and click here.


Discover the magazine "MSD Health Literacy Well Done Awards" in Dutch or French.